Medication Therapy Management Fishbowl Summary
The American Pharmacists Association Foundation’s Asheville Project created a community-based, medication therapy management (MTM) program for patients with hypertension/ dyslipidemia. In this program, pharmacists provide both education and long-term medication therapy management to reduce the risks of hypertension and dyslipidemia. The program, provided over a 6-year period in 12 community and hospital pharmacy clinics in Asheville, N.C., resulted in both clinical and financial benefits. This program resulted in numerous clinical benefits, including reduced hemoglobin A1C levels, improved blood pressure control, and significant declines in cholesterol and serum triglyceride levels. The program also reduced costs across four targeted conditions (diabetes, asthma, cardiovascular disease, and depression) and produced a positive return on investment.
- Barry Bunting is the Vice President of Clinical Services for American Health Care.
- Susan Ladd, CDC, and Deborah Carpenter, Westat
- Ben Bluml is the Vice President for Research at the American Pharmacists Association Foundation. [Perspective: Pharmacy Profession]
- Mark Smith is the Director of MedStar Institute for Innovation and the Chairman and Professor of Emergency Medicine at Georgetown University School of Medicine. [Perspective: Physician Profession]
- Andrew Webber is President and CEO of the National Business Coalition on Health (NBCH). [Perspective: Purchaser]
- Adam Zavadil is the Director of Market Strategy and Analysis at the Alliance of Community Health Plans [Perspective: Insurers]
The presentation with accompanying audio is available at http://millionhearts.hhs.gov/aboutmh/innovation_exchange/Bunting/index.htm.
A full description of the innovation appears in the AHRQ Health Care Innovations Exchange at http://www.innovations.ahrq.gov/node/4963.